EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Verification of a previously obtained EQA based MUC1/CA15-3 harmonisation procedure

Huub H van Rossum iD, Theodora C Linders iD, Henk Huijgen, Ruben E A Musson, Ayşe Y Demir, Michael J Duffy iD, Melanie Moore iD

Tumor Biology · 2026-11 · 48

DOI: 10.1177/14230380261504697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tumor Biology, online erschienen am 04.11.2026. Verfasst von Huub H van Rossum und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Mucin-1, Breast Neoplasms, Biomarkers, Tumor, Antigens, Tumor-Associated, Carbohydrate. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

MUC1/CA 15-3 is the most widely used circulating marker for monitoring treatment in patients with advanced breast cancer. Previous studies demonstrated that MUC1/CA 15-3 tests are insufficiently harmonised and an EQA-based harmonisation procedure has been developed. This study aims to validate the obtained MUC1/CA 15-3 harmonisation procedure and to explore the suitability of MUC1/CA 15-3 materials as a base for developing future MUC1/CA 15-3 reference materials.

Methods

Sera from 45 patients were obtained and five additional samples were prepared from commercial MUC1/CA 15-3 materials. All samples were analyzed by measurement procedures of Abbott Alinity, Beckman DxI, Roche Cobas and Siemens Atellica. Data analysis included application of the previously obtained MUC1/CA 15-3 harmonisation procedure that required recalibration of Beckman DxI only, pre-and post-harmonisation Passing-Bablok regression, Spearman correlation coefficient and Bland-Altman difference analyses. Suitability of the MUC1/CA 15-3 materials as basis of future standards was also investigated.

Results

The slopes obtained from the regression analysis of individual MUC1/CA15-3 assays ranged from 0.598 to 1.96 pre-harmonisation and 0.8448 to 1.150 post-harmonisation. The mean difference of individual measurement procedures with the consensus mean improved from −26.65% to 22.83% before harmonisation to −12.78% to 10.95% after harmonisation. The difference between the MUC1/CA 15-3 spiked materials and the patient sample mean differences were ≤10,1% and fell within the 95% limits of agreement.

Conclusions

The EQA-based mathematical harmonisation procedure for MUC1/CA 15-3 resulted in improved MUC1/CA 15-3 harmonisation with real-world clinical samples. The MUC1/CA 15-3 materials provided a suitable base for further exploration as reference materials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucin-1Breast NeoplasmsBiomarkers, TumorAntigens, Tumor-Associated, CarbohydrateHumansFemaleReference Standards

Stichwörter der Autor:innen

CA 15-3MUC1breast cancerexternal quality assessmentharmonizationreference materialtraceabilitytumor marker

Substanzen

Mucin-1MUC1 protein, humanBiomarkers, TumorAntigens, Tumor-Associated, Carbohydrate

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Klinisch Chemisch Laboratorium, Rode Kruis Ziekenhuis, Beverwijk, The Netherlands.
  • Central Diagnostic Laboratory, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Department of Laboratory Medicine, Meander Medical Centre, Amersfoort, The Netherlands.
  • UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
  • Clinical Research Centre, St Vincent's Hospital, Dublin, Ireland.

ORCID-Profile: Huub H van Rossum, Theodora C Linders, Michael J Duffy, Melanie Moore

Zitieren

APA

van Rossum, H. H., Linders, T. C., Huijgen, H., Musson, R. E. A., Demir, A. Y., Duffy, M. J., & Moore, M. (2026). Verification of a previously obtained EQA based MUC1/CA15-3 harmonisation procedure. Tumor Biology, 48. https://doi.org/10.1177/14230380261504697

Vancouver

van Rossum HH, Linders TC, Huijgen H, Musson REA, Demir AY, Duffy MJ, et al. Verification of a previously obtained EQA based MUC1/CA15-3 harmonisation procedure. Tumor Biology. 2026;48. doi:10.1177/14230380261504697

BibTeX
@article{vanRossum2026,
  author = {van Rossum, Huub H and Linders, Theodora C and Huijgen, Henk and Musson, Ruben E A and Demir, Ayşe Y and Duffy, Michael J and Moore, Melanie},
  title = {Verification of a previously obtained EQA based MUC1/CA15-3 harmonisation procedure},
  journal = {Tumor Biology},
  year = {2026},
  volume = {48},
  doi = {10.1177/14230380261504697}
}
Kostenlos starten →